Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Regulation of vaping products designed to improve the lives of adult smokers. Support proposals to prohibit the sale of tobacco or vaping products to individuals under the age of 21. H.R. 2411/S. 1258, Tobacco to 21 Act.
Regulation of e-cigarettes and vaping products designed to improve the lives of adult smokers. Support proposals to prohibit the sale of tobacco or vaping products to individuals under the age of 21. H.R. 2411/S. 1258.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
JUUL LABS INC. via THE WATTS GROUP PLLC
2020 · third_quarter · Q3
Regulation of electronic nicotine delivery system products as a less harmful alternative for adult smokers.
Regulation of electronic nicotine delivery products as a less harmful alternative for adult smokers.
Source: Senate LDA
Regulation of e-cigarettes and vaping products designed to improve the lives of adult smokers. Support proposals to prohibit the sale of tobacco or vaping products to individuals under the age of 21. H.R. 2411/S. 1258.
Regulation of e-cigarettes and vaping products designed to improve the lives of adult smokers. Support proposals to prohibit the sale of tobacco or vaping products to individuals under the age of 21. H.R. 2411/S. 1258.
Regulation of e-cigarettes and vaping products designed to improve the lives of adult smokers. Support proposals to prohibit the sale of tobacco or vaping products to individuals under the age of 21. H.R. 2411/S. 1258.
Medical innovation, gene therapy, health care costs, newborn screening saves lives reauthorization. S. 2543; H.R. 3.
Regulation of e-cigarettes and vaping products designed to improve the lives of adult smokers. Support proposals to prohibit the sale of tobacco or vaping products to individuals under the age of 21. H.R. 2411/S. 1258.
Regulation of e-cigarettes and vaping products designed to improve the lives of adult smokers. Support proposals to prohibit the sale of tobacco or vaping products to individuals under the age of 21. H.R. 2411/S. 1258.
Regulation of e-cigarettes and vaping products designed to improve the lives of adult smokers. Support proposals to prohibit the sale of tobacco or vaping products to individuals under the age of 21. H.R. 2411/S. 1258.
Regulation of e-cigarettes and vaping products designed to improve the lives of adult smokers. Support proposals to prohibit the sale of tobacco or vaping products to individuals under the age of 21. H.R. 2411/S. 1258.
Regulation of vaping products designed to improve the lives of adult smokers. Support proposals to prohibit the sale of tobacco or vaping products to individuals under the age of 21. H.R. 2411/S. 1258, Tobacco to 21 Act.
Medical innovation, gene therapy, health care costs, newborn screening saves lives reauthorization. S. 2543; H.R. 3.
Higher Education Reform and Opportunity Act of 2017
Client: SHIRE PHARMACEUTICALS LLC · Firm: THE WATTS GROUP PLLC
S. 1194, Medical Nutrition Equity Act; H.R. 4274, Medicare IVIG Access Enhancement Act
Medicare IVIG Access Enhancement Act
Client: SHIRE PHARMACEUTICALS LLC · Firm: THE WATTS GROUP PLLC
S. 1194, Medical Nutrition Equity Act; H.R. 4724, Medicare IVIG Access Enhancement Act
Medicare IVIG Access Enhancement Act
Client: SHIRE PHARMACEUTICALS LLC · Firm: THE WATTS GROUP PLLC
S. 1194, Medical Nutrition Equity Act; H.R. 4724, Medicare IVIG Access Enhancement Act
Medicare IVIG Access Enhancement Act
Client: SHIRE PHARMACEUTICALS LLC · Firm: THE WATTS GROUP PLLC
S. 1194, Medical Nutrition Equity Act; H.R. 4724, Medicare IVIG Access Enhancement Act
Medicare IVIG Access Enhancement Act
Client: SHIRE PHARMACEUTICALS LLC · Firm: THE WATTS GROUP PLLC
S. 1194, Medical Nutrition Equity Act; H.R. 4724, Medicare IVIG Access Enhancement Act
Medicare IVIG Access Enhancement Act
Client: SHIRE PHARMACEUTICALS LLC · Firm: THE WATTS GROUP PLLC
S. 1194, Medical Nutrition Equity Act; H.R. 4724
Medical Nutrition Equity Act of 2017
Client: SHIRE PHARMACEUTICALS LLC · Firm: THE WATTS GROUP PLLC
S. 1194, Medical Nutrition Equity Act; H.R. 4724, Medicare IVIG Access Enhancement Act
Medical Nutrition Equity Act of 2017
Client: SHIRE PHARMACEUTICALS LLC · Firm: THE WATTS GROUP PLLC
S. 1194, Medical Nutrition Equity Act; H.R. 4724
Medical Nutrition Equity Act of 2017
Client: SHIRE PHARMACEUTICALS LLC · Firm: THE WATTS GROUP PLLC
S. 1194, Medical Nutrition Equity Act; H.R. 4724, Medicare IVIG Access Enhancement Act
Medical Nutrition Equity Act of 2017
Client: SHIRE PHARMACEUTICALS LLC · Firm: THE WATTS GROUP PLLC
S. 1194, Medical Nutrition Equity Act; H.R. 4724, Medicare IVIG Access Enhancement Act
Medical Nutrition Equity Act of 2017
Client: SHIRE PHARMACEUTICALS LLC · Firm: THE WATTS GROUP PLLC
S. 1194, Medical Nutrition Equity Act; H.R. 4724, Medicare IVIG Access Enhancement Act
Medical Nutrition Equity Act of 2017
Client: SHIRE PHARMACEUTICALS LLC · Firm: THE WATTS GROUP PLLC
S. 1194, Medical Nutrition Equity Act; H.R. 4274, Medicare IVIG Access Enhancement Act
Regulation of electronic nicotine delivery system products as a less harmful alternative for adult smokers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JUUL LABS INC. via THE WATTS GROUP PLLC
2020 · second_quarter · Q2
Regulation of electronic nicotine delivery system products as a less harmful alternative for adult smokers.
Regulation of electronic nicotine delivery system products as a less harmful alternative for adult smokers.
Regulation of electronic nicotine delivery products as a less harmful alternative for adult smokers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS via THE WATTS GROUP PLLC
2020 · first_quarter · 1T
Gene therapy innovation
State Medicaid system, innovation, Value Based Arrangements. Newborn screening saves lives reauthorization.
Medical innovation, gene therapy, health care costs, newborn screening saves lives reauthorization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JUUL LABS INC. via THE WATTS GROUP PLLC
2020 · first_quarter · Q1
Regulation of vaping products designed to improve the lives of adult smokers.
Regulation of vaping products designed to improve the lives of adult smokers.
Regulation of vaping products designed to improve the lives of adult smokers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JUUL LABS INC. via THE WATTS GROUP PLLC
2019 · fourth_quarter · 4A
Regulation of vaping products designed to improve the lives of adult smokers.
Regulation of vaping products designed to improve the lives of adult smokers. Support proposals to prohibit the sale of tobacco or vaping products to individuals under the age of 21. H.R. 2411/S. 1258, Tobacco to 21 Act.
Regulation of vaping products designed to improve the lives of adult smokers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS via THE WATTS GROUP PLLC
2019 · third_quarter · 3A
State Medicaid system, innovation, Value Based Arrangements
Gene therapy innovation
Medical innovation, gene therapy, health care costs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS via THE WATTS GROUP PLLC
2019 · fourth_quarter · 4A
Medical innovation, gene therapy, health care costs, newborn screening saves lives reauthorization. S. 2543; H.R. 3.
State Medicaid system, innovation, Value Based Arrangement. Newborn screening saves lives reauthorization.
Gene therapy innovation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JUUL LABS INC. via THE WATTS GROUP PLLC
2019 · fourth_quarter · RR
Regulation of e-cigarettes and vaping products designed to improve the lives of adult smokers. Support proposals to prohibit the sale of tobacco or vaping products to individuals under the age of 21. H.R. 2411/S. 1258.
Regulation of e-cigarettes and vaping products designed to improve the lives of adult smokers. Support proposals to prohibit the sale of tobacco or vaping products to individuals under the age of 21. H.R. 2411/S. 1258.
Regulation of e-cigarettes and vaping products designed to improve the lives of adult smokers. Support proposals to prohibit the sale of tobacco or vaping products to individuals under the age of 21. H.R. 2411/S. 1258.
NOVARTIS via THE WATTS GROUP PLLC
2019 · third_quarter · RR
Gene therapy; health care innovation; health care costs
Gene therapy; health care innovation; health care costs
SHIRE PHARMACEUTICALS LLC via THE WATTS GROUP PLLC
2019 · first_quarter · 1T
Health care costs, coverage and reimbursement; and new born screening.
Health care cost, coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHIRE PHARMACEUTICALS LLC via THE WATTS GROUP PLLC
2018 · third_quarter · Q3
S. 1194, Medical Nutrition Equity Act; H.R. 4724
S. 1194, Medical Nutrition Equity Act; H.R. 4724, Medicare IVIG Access Enhancement Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHIRE PHARMACEUTICALS LLC via THE WATTS GROUP PLLC
2018 · fourth_quarter · Q4
S. 1194, Medical Nutrition Equity Act; H.R. 4724, Medicare IVIG Access Enhancement Act
S. 1194, Medical Nutrition Equity Act; H.R. 4274, Medicare IVIG Access Enhancement Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHIRE PHARMACEUTICALS LLC via THE WATTS GROUP PLLC
2018 · third_quarter · RR
S. 1194, Medical Nutrition Equity Act; H.R. 4724, Medicare IVIG Access Enhancement Act
S. 1194, Medical Nutrition Equity Act; H.R. 4724, Medicare IVIG Access Enhancement Act
Regulation of e-cigarettes and vaping products designed to improve the lives of adult smokers. Support proposals to prohibit the sale of tobacco or vaping products to individuals under the age of 21. H.R. 2411/S. 1258.